AtaiBeckley Weighs BPL-003 Deal After Strong Phase 2a And FDA Support
AtaiBeckley (NasdaqGM:ATAI) reported positive, peer reviewed Phase 2a results for its lead psychedelic drug BPL-003 in ...
Yahoo
FDA-approved nasal spray helps patients with treatment-resistant depression
Add Yahoo as a preferred source to see more of our stories on Google. ABC News’ Ike Ejiochi follows two patients taking an FDA-approved esketamine nasal spray for their treatment-resistant depression ...
Hosted on MSN
FDA-approved nasal spray helps patients with treatment-resistant depression
ABC News’ Ike Ejiochi follows two patients taking an FDA-approved esketamine nasal spray for their treatment-resistant depression to better understand the drug’s effects. White House calls new ...
Medscape
FDA Removes Age Restriction for Neffy Nasal Spray
The FDA updates neffy nasal spray labeling, removing the age restriction for emergency allergy treatment in patients who meet ...
WFTV
FDA approves Johnson & Johnson’s oral pill for psoriasis, company says
The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson’s oral pill for psoriasis, the company said. In a news release, Johnson & Johnson said that the FDA approved Icotyde ...
mlive
Ann Arbor pharmaceutical company acquires nasal spray treatment manufacturer
Esperion announced Wednesday it has completed its acquisition of Corstasis Therapeutics Inc., gaining the first FDA-approved ...